North Point Portfolio Managers Corp Abbott Laboratories Transaction History

North Point Portfolio Managers Corp

  • $590 Million
  • Q3 2024

A detailed history of North Point Portfolio Managers Corp transactions in Abbott Laboratories stock. As of the latest transaction made, North Point Portfolio Managers Corp holds 100,487 shares of ABT stock, worth $11.6 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
100,487
Previous 101,848 1.34%
Holding current value
$11.6 Million
Previous $10.6 Million 8.25%
% of portfolio
1.94%
Previous 1.88%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$100.07 - $118.13 $136,195 - $160,774
-1,361 Reduced 1.34%
100,487 $11.5 Million
Q2 2024

Jul 29, 2024
SELL
$100.73 - $112.44 $37,572 - $41,940
-373 Reduced 0.36%
101,848 $10.6 Million
Q1 2024

Apr 23, 2024
SELL
$109.52 - $120.96 $201,735 - $222,808
-1,842 Reduced 1.77%
102,221 $11.6 Million
Q4 2023

Jan 23, 2024
SELL
$90.19 - $110.4 $80,990 - $99,139
-898 Reduced 0.86%
104,063 $11.5 Million
Q3 2023

Oct 26, 2023
SELL
$95.53 - $114.62 $20,634 - $24,757
-216 Reduced 0.21%
104,961 $10.2 Million
Q2 2023

Jul 24, 2023
SELL
$100.78 - $112.29 $2.95 Million - $3.28 Million
-29,245 Reduced 21.76%
105,177 $11.5 Million
Q1 2023

Apr 25, 2023
BUY
$96.86 - $114.01 $80,878 - $95,198
835 Added 0.63%
134,422 $13.6 Million
Q4 2022

Jan 24, 2023
BUY
$95.06 - $111.52 $82,512 - $96,799
868 Added 0.65%
133,587 $0
Q3 2022

Oct 25, 2022
SELL
$96.76 - $112.03 $198,164 - $229,437
-2,048 Reduced 1.52%
132,719 $12.8 Million
Q2 2022

Jul 27, 2022
SELL
$102.07 - $123.37 $156,575 - $189,249
-1,534 Reduced 1.13%
134,767 $14.6 Million
Q1 2022

Apr 26, 2022
SELL
$114.02 - $139.04 $9,919 - $12,096
-87 Reduced 0.06%
136,301 $16.1 Million
Q4 2021

Jan 26, 2022
SELL
$115.53 - $141.46 $493,197 - $603,892
-4,269 Reduced 3.04%
136,388 $19.2 Million
Q3 2021

Oct 20, 2021
SELL
$116.66 - $129.06 $217,454 - $240,567
-1,864 Reduced 1.31%
140,657 $16.6 Million
Q2 2021

Jul 28, 2021
SELL
$105.79 - $124.53 $42,739 - $50,310
-404 Reduced 0.28%
142,521 $16.5 Million
Q1 2021

Apr 26, 2021
SELL
$108.84 - $128.23 $45,603 - $53,728
-419 Reduced 0.29%
142,925 $17.1 Million
Q4 2020

Jan 28, 2021
BUY
$105.0 - $114.42 $6,825 - $7,437
65 Added 0.05%
143,344 $15.7 Million
Q3 2020

Oct 27, 2020
SELL
$91.64 - $111.29 $194,460 - $236,157
-2,122 Reduced 1.46%
143,279 $15.6 Million
Q2 2020

Jul 28, 2020
SELL
$76.57 - $98.0 $512,789 - $656,306
-6,697 Reduced 4.4%
145,401 $13.3 Million
Q1 2020

Apr 28, 2020
SELL
$62.82 - $91.86 $320,067 - $468,026
-5,095 Reduced 3.24%
152,098 $12 Million
Q4 2019

Feb 20, 2020
SELL
$78.51 - $87.4 $636,637 - $708,726
-8,109 Reduced 4.91%
157,193 $13.7 Million
Q3 2019

Oct 31, 2019
SELL
$81.84 - $88.74 $160,242 - $173,752
-1,958 Reduced 1.17%
165,302 $13.8 Million
Q2 2019

Aug 02, 2019
SELL
$72.88 - $85.0 $34,326 - $40,035
-471 Reduced 0.28%
167,260 $14.1 Million
Q1 2019

Apr 24, 2019
SELL
$66.22 - $80.06 $2.75 Million - $3.33 Million
-41,588 Reduced 19.87%
167,731 $13.4 Million
Q4 2018

Jan 24, 2019
SELL
$65.56 - $74.27 $1.12 Million - $1.27 Million
-17,055 Reduced 7.53%
209,319 $15.1 Million
Q3 2018

Oct 26, 2018
SELL
$60.81 - $73.36 $382,920 - $461,947
-6,297 Reduced 2.71%
226,374 $16.6 Million
Q2 2018

Jul 26, 2018
SELL
$57.57 - $63.54 $341,908 - $377,364
-5,939 Reduced 2.49%
232,671 $14.2 Million
Q1 2018

Apr 25, 2018
SELL
$56.27 - $63.62 $62,572 - $70,745
-1,112 Reduced 0.46%
238,610 $14.3 Million
Q4 2017

Jan 24, 2018
SELL
$53.68 - $57.47 $554,192 - $593,320
-10,324 Reduced 4.13%
239,722 $13.7 Million
Q3 2017

Oct 30, 2017
BUY
$48.06 - $53.64 $12 Million - $13.4 Million
250,046
250,046 $13.3 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track North Point Portfolio Managers Corp Portfolio

Follow North Point Portfolio Managers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Point Portfolio Managers Corp, based on Form 13F filings with the SEC.

News

Stay updated on North Point Portfolio Managers Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email